封面
市場調查報告書
商品編碼
1447710

腸外營養袋市場:到 2031 年按腔室類型、消費者和最終用戶劃分的全球預測

Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags), Consumer (Adults, Children), End User (Healthcare Facilities, Pharmacies & Compounding Service Providers) - Global Forecast to 2031

出版日期: | 出版商: Meticulous Research | 英文 111 Pages | 訂單完成後即時交付

價格

預計到 2031 年,全球腸外營養袋市場將達到 12.5 億美元,2024 年至 2031 年複合年增長率為 6.6%。

該報告基於全面的一手和二手研究以及對市場情景的深入分析,提供了該行業的關鍵驅動因素、限制因素以及市場驅動因素/挑戰。 該市場是由全球營養不良盛行率上升、早產數量增加以及代謝紊亂發病率上升所推動的。

此外,家庭醫療保健的日益普及、全球老年人口的增加以及新興經濟體為該市場帶來了巨大的成長機會。 然而,對腸外營養相關感染風險的擔憂正在限制該市場的成長。 新興國家對腸外營養缺乏認知是影響腸外營養袋市場成長的主要挑戰。

在腔室類型中,單腔腸外營養袋細分市場預計將在 2024 年佔據腸外營養袋市場的最大份額。 單室腸外營養袋是將電解質、胺基酸、脂類、維生素、碳水化合物、微量元素等營養液全面配製並儲存於一個隔間中,用於腸外給藥。 此細分市場所佔份額較大的原因是單室空袋的廣泛使用、單室營養袋的處方率高、感染風險降低、處方和劑量錯誤風險降低。袋子數量較少,與兩室或多室袋相比更具成本效益。

在消費者中,預計到 2024 年,成人細分市場將佔據腸外營養袋市場的最大份額。 手術數量的增加、住院率的上升、老年人口的增加以及成人胃腸道疾病盛行率的增加是支撐最大市場份額的因素。 例如,2020年,羅馬全球流行病學研究基金會透露,世界上有40%的人患有腸腦交互作用障礙(DGBI),如腸躁症、功能性消化不良和功能性腹痛症候群。它。 這些患者大多數需要腸外營養袋來獲得所需的營養。

在最終用戶中,醫療機構預計到 2024 年將佔據腸外營養袋市場的最大份額。 此細分市場佔有較大的市場份額是由於到醫院、診所診治疾病的患者數量較多、疾病負擔增加、腸外營養處方率增加、配藥量增加等因素造成的。醫院附屬藥房擁有先進的配藥裝置.

對全球腸外營養袋市場區域狀況的詳細分析提供了五個關鍵區域的詳細定性和定量見解。 預計到2024年,北美將佔據全球腸外營養袋市場的最大份額,其次是歐洲、亞太地區、拉丁美洲以及中東和非洲。 這種增長主要是由於慢性病和傳染病的流行、早產兒數量的增加以及家庭護理環境的日益採用而導致對腸外營養的需求增加。 例如,根據世界衛生組織 (WHO) 的數據,2020 年約有 1,340 萬名嬰兒早產(妊娠 37 週前)。 由於無法口服餵養,早產兒通常必須進行腸外餵養,從而增加了對腸外營養的需求並支持市場成長。

目錄

第 1 章簡介

第 2 章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 市場
  • 摘要
  • 影響市場成長的因素
    • 市場動態影響分析
    • 因素分析
  • 主要趨勢
    • 越來越多地採用居家醫療保健
    • 擴大乙烯醋酸乙烯酯 (EVA) 在胃腸外應用的使用
  • 監理分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
    • 拉丁美洲
      • 巴西
      • 墨西哥
    • 中東/非洲
  • 波特五力分析

第 5 章腸外營養袋市場:依腔室類型

  • 摘要
  • 單室腸外營養袋
  • 雙室腸外營養袋
  • 多室腸外營養袋

第 6 章腸外營養袋市場:依消費者分類

  • 摘要
  • 成人
  • 兒童

第 7 章腸外營養袋市場:依最終使用者劃分

  • 摘要
  • 醫療設施
  • 藥局/配藥服務提供者

第 8 章腸外營養袋市場:依地區

  • 摘要
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 9 章競爭分析

  • 摘要
  • 產品組合分析
  • 競爭基準測試

第 10 章公司簡介

  • B. Braun SE
  • Baxter International, Inc.
  • Fresenius Kabi Ag(A Subsidiary of Fresenius SE & Co. KGaA)
  • GVS S.p.A.
  • Grifols, S.A.
  • Technoflex
  • RENOLIT SE
  • Valmed s.r.l.
  • HEMEDIS GmbH
  • INFRA Srl
  • Beijing L&Z Medical Technology Development Co., Ltd.
  • Boen Healthcare Co., Ltd
  • AdvaCare Pharma
  • Diffuplast S.r.l.

第 11 章附錄

Product Code: MRHC - 1041109

The global parenteral nutrition bags market is projected to reach $1.25 billion by 2031, at a CAGR of 6.6% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the rising global prevalence of malnutrition, the large number of premature births, and the increasing incidence of metabolic disorders.

Furthermore, the growing adoption of home healthcare, the rising global geriatric population, and emerging economies provide significant growth opportunities for this market. However, concerns over the infection risks associated with parenteral nutrition restrain the growth of this market. The lack of awareness regarding parenteral nutrition in developing countries is a major challenge impacting the growth of the parenteral nutrition bags market.

Among chamber types, in 2024, the single-chamber parenteral nutrition bags segment is expected to account for the largest share of the parenteral nutrition bags market. Single-chamber parenteral nutrition bags are designed to compound and store a comprehensive blend of nutritional solutions, including electrolytes, amino acids, lipids, vitamins, carbohydrates, and trace elements within a single compartment for parenteral administration. The large share of the segment is attributed to the wide availability of single-chamber empty bags, high rate of prescription for single-chamber nutrition bags, decreased risk of infection, less prescription & administration errors, and cost-effectiveness as compared to dual or multi-chambered bags.

Among consumers, in 2024, the adults segment is expected to account for the largest share of the parenteral nutrition bags market. The rising number of surgeries, rising hospitalization rates, the growth of the geriatric population, and the increasing prevalence of gastrointestinal disorders among adults are factors supporting the largest share of the market. For instance, in 2020, the Rome Foundation of Global Epidemiology Study revealed that 40% of people worldwide suffer from diseases of the gut-brain interaction (DGBIs), such as irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome, among others. Most of these patients would require parenteral nutrition bags for the intake of the required nutrition.

Among end users, in 2024, the healthcare facilities segment is expected to account for the largest share of the parenteral nutrition bags market. The large market share of this segment is attributed to factors such as a large number of patients visiting hospitals and clinics for disease diagnosis and treatment, growing disease burden, an associated rise in the rates of prescription for parenteral nutrition, and the presence of advanced compounding equipment in the hospital associated compounding pharmacies.

An in-depth analysis of the geographical scenario of the global parenteral nutrition bags market provides detailed qualitative and quantitative insights for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global parenteral nutrition bags market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This growth is primarily driven by the growing demand for parenteral nutrition due to the prevalence of chronic & infectious diseases, the rising number of premature births, and the growing adoption of home healthcare settings. For instance, according to the World Health Organization (WHO), in 2020, approximately 13.4 million babies were born preterm (before the completion of 37 weeks of gestation). Preterm babies often require nutrients that need to be provided parenterally since oral nutrition is not possible, therefore increasing the demand for parenteral nutrition and supporting the growth of the market.

The key players operating in the global parenteral nutrition bags market are B. Braun SE (Germany), Baxter International, Inc. (U.S.), Fresenius Kabi AG (Germany), GVS S,p.A. (Italy), Grifols, S.A. (Spain), Technolflex (France), RENOLIT Healthcare (Germany), Valmed s.r.l (Italy), HEMEDIS GmbH (Germany), INFRA Srl (Italy), Beijing L&Z Medical Technology Development Co., Ltd.(China), Boen Healthcare Co., Ltd. (China), AdvaCare Pharma (U.S.), and Diffuplast S.r.l. (Italy).

Scope of the Report:

Parenteral Nutrition Bags Market Assessment-by Chamber Type

  • Single-Chamber Parenteral Nutrition Bags
  • Dual-Chamber Parenteral Nutrition Bags
  • Multi-Chambered Parenteral Nutrition Bags

Parenteral Nutrition Bags Market Assessment-by Consumer

  • Adults
  • Children

Parenteral Nutrition Bags Market Assessment-by End User

  • Healthcare Facilities
  • Pharmacies and Compounding Service Providers

Parenteral Nutrition Bags Market-by Geography

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition and Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews With Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Key Trends
    • 4.3.1. Growing Adoption of Home Healthcare
    • 4.3.2. Growing Use of Ethylene Vinyl Acetate (EVA) in Parenteral Applications
  • 4.4. Regulatory Analysis
    • 4.4.1. North America
      • 4.4.1.1. U.S.
      • 4.4.1.2. Canada
    • 4.4.2. Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
    • 4.4.4. Latin America
      • 4.4.4.1. Brazil
      • 4.4.4.2. Mexico
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of Substitutes
    • 4.5.4. Threat of New Entrants
    • 4.5.5. Degree of Competition

5. Parenteral Nutrition Bags Market Assessment- by Chamber Type

  • 5.1. Overview
  • 5.2. Single-chamber Parenteral Nutrition Bags
  • 5.3. Dual-chamber Parenteral Nutrition Bags
  • 5.4. Multi-chambered Parenteral Nutrition Bags

6. Parenteral Nutrition Bags Market Assessment-by Consumer

  • 6.1. Overview
  • 6.2. Adults
  • 6.3. Children

7. Parenteral Nutrition Bags Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Healthcare Facilities
  • 7.3. Pharmacies & Compounding Service Providers

8. Parenteral Nutrition Bags Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
  • 8.3. Europe
  • 8.4. Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Product Portfolio Analysis
  • 9.3. Competitive Benchmarking

10. Company Profiles

  • 10.1. B. Braun SE
  • 10.2. Baxter International, Inc.
  • 10.3. Fresenius Kabi Ag (A Subsidiary of Fresenius SE & Co. KGaA)
  • 10.4. GVS S.p.A.
  • 10.5. Grifols, S.A.
  • 10.6. Technoflex
  • 10.7. RENOLIT SE
  • 10.8. Valmed s.r.l.
  • 10.9. HEMEDIS GmbH
  • 10.10. INFRA Srl
  • 10.11. Beijing L&Z Medical Technology Development Co., Ltd.
  • 10.12. Boen Healthcare Co., Ltd
  • 10.13. AdvaCare Pharma
  • 10.14. Diffuplast S.r.l.

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports
  • Table 1 Healthcare Expenditure as a Percentage of GDP, by Country, 2020 Vs. 2021 (%)
  • Table 2 Number of Physicians Per 1,000 Population, by Country, 2020
  • Table 3 Infant Mortality Rates (Deaths Per 1,000 Live Births), by Country, 2010 Vs. 2019 Vs. 2021
  • Table 4 Global Prevalence of Undernourishment (% of Population), by Country, 2021
  • Table 5 Canada: Medical Device Approval Procedures, by Class
  • Table 6 China: Medical Device Approval Procedures, by Class
  • Table 7 Rest of APAC: Authorities Regulating Medical Devices, by Country
  • Table 8 Brazil: Medical Device Approval Procedures, by Class
  • Table 9 Rest of Latin America: Medical Device Regulatory Systems
  • Table 10 South Africa: Medical Device Approval Procedures, by Class
  • Table 11 Global Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 12 Global Single-Chamber Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 13 Global Dual-Chamber Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 14 Global Multi-Chambered Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 15 Global Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 16 Global Parenteral Nutrition Bags Market for Adults, by Region, 2022-2031(USD Million)
  • Table 17 Global Parenteral Nutrition Bags Market for Children, by Region, 2022-2031 (USD Million)
  • Table 18 Global Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 19 Global Parenteral Nutrition Bags Market for Healthcare Facilities, by Region, 2022-2031 (USD Million)
  • Table 20 Global Parenteral Nutrition Bags Market for Pharmacies & Compounding Service Providers, by Region, 2022-2031 (USD Million)
  • Table 21 Global Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 22 North America: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 23 North America: Parenteral Nutrition Bags Market, by Consumer, 2022-2031(USD Million)
  • Table 24 North America: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 25 Europe: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 26 Europe: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 27 Europe: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 28 Asia-Pacific: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 29 Asia-Pacific: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 30 Asia-Pacific: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 31 Latin America: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 32 Latin America: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 33 Latin America: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 34 Middle East & Africa: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 35 Middle East & Africa: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 36 Middle East & Africa: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 37 Product Portfolio Analysis

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Parenteral Nutrition Bags Market, by Chamber Type, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Parenteral Nutrition Bags Market, by Consumer, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Parenteral Nutrition Bags Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Parenteral Nutrition Bags Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Percentage of Population Aged 65 Years or Over, by Region, 2022 Vs. 2030 (%)
  • Figure 13 Global Estimated Number of New Cancer Cases, 2020-2040 (In Million)
  • Figure 14 U.S. FDA Regulatory Pathways
  • Figure 15 India: Medical Device Regulatory Pathway
  • Figure 16 Porter's Five Forces Analysis
  • Figure 17 Global Parenteral Nutrition Bags Market, by Chamber Type, 2024 Vs. 2031 (USD Million)
  • Figure 18 Global Parenteral Nutrition Bags Market, by Consumer, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global Parenteral Nutrition Bags Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 20 Global Parenteral Nutrition Bags Market, by Region, 2024 Vs. 2031 (USD Million)
  • Figure 21 North America: Parenteral Nutrition Bags Market Snapshot
  • Figure 22 Europe: Parenteral Nutrition Bags Market Snapshot
  • Figure 23 Asia-Pacific: Parenteral Nutrition Bags Market Snapshot
  • Figure 24 Latin America: Parenteral Nutrition Bags Market Snapshot
  • Figure 25 Middle East & Africa: Parenteral Nutrition Bags Market Snapshot
  • Figure 26 Parenteral Nutrition Bags Market: Competitive Benchmarking (Based on Chamber Type)
  • Figure 27 Parenteral Nutrition Bags Market: Competitive Benchmarking (Based on Geography)
  • Figure 28 B. Braun SE: Financial Overview (2022)
  • Figure 29 Baxter International, Inc.: Financial Overview (2023)
  • Figure 30 Fresenius Se & Co. KGaA: Financial Overview (2022)
  • Figure 31 GVS S.p.A.: Financial Overview (2022)
  • Figure 32 Grifols, S.A.: Financial Overview (2022)
  • Figure 33 RENOLIT SE: Financial Overview (2022)